[Psilocybin fungi microdose treatment in major depressive disorder: a case report].
Vertex (Buenos Aires, Argentina) July 10, 2024 Mariana Zarankin, María S Pellegrini, Francisco Zenteno 2 citations
A 19-year-old patient with major depressive syndrome achieved complete symptomatic remission after a 7-month program of self-administered psilocybin microdoses, supported by weekly evaluations, clinical anamnesis, laboratory tests, and the Hamilton depression scale. Conventional pharmacological treatment was suspended without discontinuation symptoms, and improvements in communication, social interaction, and general well-being were observed. The authors suggest that psilocybin microdose treatments are promising tools for depression but note that scientific studies are needed to certify these findings.